Role of Circulating Tumor DNA in Adapting Immunotherapy Approaches in Breast Cancer
Immunotherapy has a defined role in the treatment of both early- and late-stage triple-negative breast cancer (TNBC) and is under active exploration in human epidermal receptor 2-positive as well as high-risk hormone-receptor-positive subtypes. It is critical to balance the efficacy and toxicity of...
Saved in:
| Main Authors: | Sudhir Kumar, Rossanna C. Pezo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | Current Oncology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1718-7729/32/7/373 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A comparative study of four cell-free DNA assays for detecting circulating tumor DNA in early breast cancer
by: Charlotta V. Mulder, et al.
Published: (2025-07-01) -
The emerging role of circulating tumor DNA in brain tumor research
by: Amir Modarresi Chahardehi, et al.
Published: (2025-06-01) -
Effects of exercise on inflammation, circulating tumor cells, and circulating tumor DNA in colorectal cancer
by: Justin C. Brown, et al.
Published: (2025-12-01) -
Longitudinal profiling of hormone receptor positive, HER2 negative metastatic breast cancer through droplet digital PCR-based circulating tumor DNA fragmentomics
by: Lorenzo Foffano, et al.
Published: (2025-09-01) -
Predictive Factors of Response to Neoadjuvant Chemotherapy (NACT) and Immune Checkpoint Inhibitors in Early-Stage Triple-Negative Breast Cancer Patients (TNBC)
by: Khashayar Yazdanpanah Ardakani, et al.
Published: (2025-07-01)